As of 2025-03-21, the Relative Valuation of Talaris Therapeutics Inc (TALS) is (28.21) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.72 USD, the upside of Talaris Therapeutics Inc based on Relative Valuation is -1137.1%.
The range of the Relative Valuation is (26.37) - (40.59) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.1x - 26.6x | 16.7x |
| Forward P/E multiples | 14.2x - 23.2x | 15.6x |
| Fair Price | (26.37) - (40.59) | (28.21) |
| Upside | -1069.6% - -1592.4% | -1137.1% |
| Date | P/E |